Pyxis Oncology, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Pyxis Oncology, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 15, 2026, to elect directors and ratify auditor appointment.
NASDAQ
Pyxis Oncology will hold its annual stockholders meeting on June 11, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
NASDAQ
Pyxis Oncology announces its 2025 Annual Meeting of Stockholders to be held virtually on June 18, 2025, featuring proposals for director elections and auditor ratification.
NASDAQ
Pyxis Oncology is asking stockholders to approve an amendment to its 2021 Equity and Incentive Plan to increase the available shares by 5,500,000 at a special meeting on October 23, 2024.
NASDAQ
Pyxis Oncology will hold its annual stockholders meeting on June 11, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
NASDAQ
Pyxis Oncology announces its 2024 Annual Meeting of Stockholders to be held virtually on June 11, 2024, to vote on director elections and the ratification of its independent accounting firm.